SEPTIN9 and colorectal carcinoma: The primary objective of this research project was to explore the potential of methylation levels of well-known Septin-9 (SEPT9) and introduce a novel gene, Heart and Neural Crest Derivatives Expressed 1 (HAND1), in plasma ctDNA as the putative biomarker for diagnosing CRC.